Home
About
Pricing
Log In
Back
RNV
Asset Logo

ReNerve Limited

🇦🇺 ASX

🩺 HEALTH CARE

Compare
Add to watchlist
👑 Overview

📈 Performance

💵 Cost

🤓 Advanced

👨‍👩‍👧‍👦 Community

📈

-72.11%
Growth

8 months capital growth

💵

$ 500
Minimum Order

Due to regulatory requirements

🌏

1
Pearlers Invested

Since January 2020

👑 Overview

Key information
🔎 Fund Overview

ReNerve Ltd. is a medical device company focused on the repair of peripheral nerve injuries. The company is focused on developing products that accelerate tissue regeneration while preventing scarring and negative inflammatory responses. Its products include NervAlign Nerve Cuff, NervAlign Nerve Graft and NervAlign Bionic Nerve. NervAlign Nerve Cuff is a soft, compatible protective wrap used to protect repaired injured nerves. The product is being developed for the surgical repair of transected (cut) and damaged nerves. NervAlign nerve grafts offers surgeons the ability to repair damaged nerves (neurotmesis) without the need to harvest the sural nerve from the patient. The company is developing, NervAlign Bionic Nerve, a combination polymer technology and its nerve graft to produce a replacement nerve that contains shaped ionic polymers which would enable the stimulation of the distal end of a nerve injury.

📈 Performance

Price History

-50.50%

1M

All Time

Graph

Table

Unsure how much or often to invest?
🗓️ Investing frequency calculator

Determine the investment frequency needed to reach your goals

Try it out →
💵 Investing amount calculator

Determine the recurring investment needed to reach your goals

Try it out →
⏱️ Investing duration calculator

Determine how long you will need to invest to reach your goals

Try it out →

💵 Costs

💵

6.50 AUD*
Purchase Fee

*$5.50 with Pearler Prepay

💼

N/A
Management Fee

Included in unit price, not charged by Pearler

💸

Want to know the long term costs?
Calculate the historic long term costs to hold your investments
💸 Net fee calculator

🤓 Advanced information

Technical Info

💰 Price*

$0.10

*Price may be up to 24 hours old

👩‍👩‍👦 Community Insights

How our community is investing

🌏 Pearlers invested in RNV

1

📊 Total Capital Earnings

N/A

🔃 Average investment frequency

13 weeks

💵 Average investment amount

$761

Last time a customer invested in RNV

179 days
RNV investor breakdown
💵 Income of investors

More than 200k

150k - 200k

100k - 150k

50k - 100k

100%

Less than 50k

👶 Age of investors

18 - 25

26 - 34

35 - 90

100%
🙋 Legal gender of investors

Female

100%

Male

Pearlers who invest in RNV also invest in...

Betashares Australian Sustainability Leaders ETF

FAIR

FAIR.AX was created on 2017-11-27 by BetaShares. The fund's investment portfolio concentrates primarily on total market equity. The fund aims to track the performance of an index (before fees and expenses) that includes Australian companies that have passed screens to exclude companies with direct or significant exposure to fossil fuels or engaged in activities deemed inconsistent with responsible investment considerations.

🙌 Performance (5Yr p.a)

6.38%

📊 Share price

$22.37 AUD

⛳️ DIVERSIFIED

Find Out More

4DS Memory Ltd. is a semiconductor development company, which engages in the provision of non-volatile memory technology, pioneering Interface switching ReRAM, for next generation gigabyte storage class memory in mobile and cloud. The company is headquartered in Perth, Western Australia. The company went IPO on 2010-12-09. The firm is engaged in the development of a non-volatile memory technology, pioneering Interface Switching resistive random-access memory (ReRAM) for gigabyte storage in mobile and cloud. Interface Switching ReRAM, an area-based ReRAM technology positioned for Storage Class Memory in mobile devices and cloud data centers. The company owns a patented Internet protocol (IP) portfolio, comprising 34 United States patents granted, which has been developed in-house to create high-density storage class memory. The 4DS Interface Switching ReRAM meets the essential requirements for Storage Class Memory close to DRAM. The firm also collaborates with imec, a research and hub in nanoelectronics and digital technologies.

🙌 Performance (5Yr p.a)

-8.80%

📊 Share price

$0.03 AUD

🤖 TECHNOLOGY

Audinate Group Ltd. engages in the provision of development and commercialization of audio-visual software and hardware. The Company’s principal activity is the development and sale of digital audiovisual (AV) networking solutions. Dante is its technology platform that distributes digital audio and video signals over computer networks. Dante comprises software and chips, cards and modules that are sold to and integrated inside the AV products of its original equipment manufacturer (OEM) customers. The firm also provides a series of products and services to AV professionals, including AVIO adapters and management and control software. Its Dante IP networking solution is used extensively in the professional live sound, commercial installation, broadcast, public address, and recording industries. Dante replaces traditional analogue cables by transmitting synchronized AV signals across large distances to multiple locations at once, using nothing more than an ethernet cable.

🙌 Performance (5Yr p.a)

4.42%

📊 Share price

$6.47 AUD

🔨 COMMERCIAL SERVICES & SUPPLIES

Botanix Pharmaceuticals Ltd. is a dermatology company, which engages in the provision of business of researching and developing dermatology and antimicrobial products. The company is headquartered in Perth, Western Australia. The Company’s lead product is Sofdra (sofpironium) topical gel, 12.45%, a prescription anticholinergic medicine used on the skin (topical), to treat excessive underarm sweating (primary axillary hyperhidrosis) in adults and children nine years of age and older. Sofdra regulates sweating at the site of application, by binding to the primary sweat receptor and thereby blocking the sweat signal. Its product pipeline targets the various skin diseases, such as BTX 1503 for Acne, BTX 1702 for Rosacea, BTX 1204A for Atopic Dermatitis, and BTX 1801 for Hemodialysis Patients. Its BTX 1503 is a transdermal gel formulation for the treatment of serious acne in adults and teenagers. BTX 1702 is used for the treatment of papulopustular rosacea. BTX 1801 is an antimicrobial gel focused on targeting Staphylococcus Aureus and Methicillin Resistant Staphylococcus Aureus (MRSA).

🙌 Performance (5Yr p.a)

34.55%

📊 Share price

$0.15 AUD

📈 HIGH PRICE GROWTH

📦 LOGISTICS

ROBO.AX was created on 2017-09-13 by Global X. The fund's investment portfolio concentrates primarily on theme equity. The ETF currently has 234.49m in AUM and 77 holdings. The Fund aims to provide investors with a return that (before fees and expenses) tracks the performance of the ROBO.AX Global Robotics and Automation Index (the Index)

🙌 Performance (5Yr p.a)

5.32%

📊 Share price

$85.89 AUD

🌏 GLOBAL

🤖 TECHNOLOGY

🏭 INDUSTRIALS

Want more shares? Try these...

Renegade Exploration Ltd. is an exploration company. The company is headquartered in Perth, Western Australia. The company went IPO on 2006-11-14. The Company’s flagship Cloncurry Copper Project is located within Queensland’s prolific North West Minerals Province and hosts a number of advanced copper prospects, including Mongoose Deeps, Mongoose West, Tank, Magazine and Mt Glorious. The firm also expanded its north-west Queensland interests by earning a 75% joint venture interest in the North Isa Project, located directly north of the George Fisher mine and approximately 40km north of Mt Isa township and controls approximately 20km of the Western Fault. The company also has a 23% interest in the Carpentaria Joint Venture (CJV) which covers a package of advanced copper and gold projects in Queensland’s Cloncurry mining district. The company also has four highly prospective projects (gold-silver and base metals) in the Walker Lane trend in Nevada, United States.

🙌 Performance (5Yr p.a)

-12.50%

📊 Share price

$0.00 AUD

⛏️ MINING

📊 Share price

$0.20 AUD
Compare
Add to watchlist